Rapid heart attack tests speed people through emergency departments

~ Next-generation bedside devices, providing a result within 15 minutes, ease pressure on overcrowded emergency departments ~

People can find out if they are having a heart attack far faster using innovative tests, according to research supported by the British Heart Foundation and presented at the American Heart Association Scientific Sessions conference in New Orleans. 

When someone with chest pain attends hospital as an emergency patient , they are given a blood test for troponin – the telltale protein released into the blood when the heart is damaged, which indicates whether they have had a heart attack. 

But doctors say that the test result from blood sent to the laboratory is often not available when they first need it to help make decisions for patients, and a result can sometimes take as long as two hours. 

A new study, led from Christchurch Hospital in New Zealand in collaboration with BHF-funded researchers at the University of Edinburgh, investigated the performance of a new type of troponin test. Blood is placed directly onto a cartridge, and analysed on the spot, with some models of the test able to reveal if someone has had a heart attack within 15 to 20 minutes. 

In the study, people given a rapid test were admitted to a ward or sent home 47 minutes faster, depending on whether it indicated they had experienced a heart attack, researchers found. This shorter stay in the emergency department, which was the average across six hospitals, was seen in comparison to troponin tests in the lab. 

The new tests, produced by various technology firms, are already in use within some British hospitals and could help to tackle long waits and overcrowding within the NHS. Researchers say they could potentially also be used in GP surgeries and chest pain clinics, potentially helping to identify people whose heart attacks might otherwise have been missed. 

Nicholas Mills, BHF Professor of Cardiology at the University of Edinburgh and a consultant interventional cardiologist at Edinburgh Royal Infirmary, helped to design the study, conducted in New Zealand.  

Professor Mills said: “When people go to the emergency department fearing they have had a heart attack, a blood sample is taken and sent to another part of the hospital for analysis in a lab.

By the time the results are available, it is likely the doctor or nurse will have been called away, so there are unfortunate and unintended delays in making decisions for patients. 

“The average turnaround for a lab troponin test can be as long as two hours, so tests which can be performed in real-time within minutes are far better for patients, reducing anxiety as they wait for an answer on what is happening to them. 

“Crucially, these tests could also ease some of the pressure on overcrowded emergency departments, helping  people move through more quickly.” 

Troponin is a protein found in the muscles, including the heart. When the heart is injured or damaged, such as during a heart attack, troponin is released into the blood. 

Hospitals used to routinely test people twice for troponin, to measure changing levels of the protein and establish if they had a heart attack. But the process was sped up, moving people through emergency departments an average of three hours faster, thanks to previous research led by the University of Edinburgh.

This showed just one troponin test could effectively identify people who were at high risk of having had a heart attack, and also the people at lower risk who could safely be sent home. 

This approach was used in the current study, but, to deliver answers to patients even more quickly, researchers investigated the new generation of devices which can analyse troponin levels in the blood on the spot.  

The study included almost 60,000 people attending an emergency department in New Zealand between February 2023 and January 2025. A faster test was given to 31,392 patients, while the rest had the standard test with blood samples sent to the laboratory. 

Those given a rapid test, compared to the lab-based test, had a 13 per cent shorter stay in the emergency department on average. That meant they were discharged or admitted to a hospital ward an average of 47 minutes faster. 

The calculation was made after taking into account other factors affecting how long people wait, such as the time of year and time of day. 

Researchers tracked all the people in their study for 30 days after they visited the emergency department, finding that the rate of people dying from cardiovascular disease or having a heart attack in that time was similar whether they were given a fast test or the regular test. 

This suggests a faster test is a safe way to decide if people should be admitted to a ward or discharged, which should not put people at extra risk by missing their heart attacks. 

The test involves a drop of blood, from a standard blood test, being placed on a cartridge which is inserted into the device. The level of troponin then appears on the screen, helping a doctor to provide a diagnosis. 

People who have not had a heart attack can be quickly reassured, thanks to a faster test. Those who have had a heart attack can receive earlier treatment with blood-thinners and be admitted directly to a specialist ward for treatment, which may include a procedure to restore the blood supply to the heart. Early treatment reduces the risk of lasting heart damage.   

Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation and consultant cardiologist, said: “Every minute matters if you are having a heart attack. And if you aren’t, you will want to be reassured or diagnosed with something different as soon as possible. 

“Troponin is the telltale protein which leaks into the bloodstream when the heart is damaged, so measuring it can be crucial for doctors to diagnose or rule out heart attacks. 

“But laboratory results can take hours to come back. So, it’s exciting to see that the bedside troponin test used in this study had a faster turnaround – providing results within minutes, and without compromising accuracy and safety. 

“Reducing delays in diagnosis is vital for patients, and also important for pressurised emergency departments working to ensure everyone gets the care they need, when they need it.” 

Breastfeeding in Scotland at highest rate ever recorded

Minister thanks NHS staff for their work supporting mothers

More than half of all babies in Scotland are now breastfed at 6 – 8 weeks, the first time this has been achieved since records began in 2002.

Latest Public Health Scotland Infant Feeding statistics for 2024-25 show that at the time of the 6-8 week review, 51% of babies were being breastfed – 34% exclusively and 17% a mixture of formula and breastfeeding. Inequalities are reducing – the numbers demonstrate that breastfeeding rates among those from the most deprived areas and younger mothers continue to increase. 

The new rates mean the Scottish Government has met the commitment to reduce the drop off in breastfeeding rates at the 6-8 week point by 10% by 2025.

The figures also reveal that 69% of newborns were breastfed for at least some time after birth (up 6% from 2016-17) – this includes an 11% increase in the most deprived areas, from 47% to 58%.

Minister for Public Health Jenni Minto said: “I welcome the news that so many babies in Scotland are now being breastfed. We will continue to protect, promote and support breastfeeding to give all babies the best nutritional start in life and to support families with their infant feeding choices as we know breastfeeding may not be possible for everyone.

“Of course, mothers benefit from support to breastfeed – from their families of course, but I also want to thank all the healthcare staff and their partner organisations who work tirelessly to educate and encourage new mums to achieve their breastfeeding goals.

“The Scottish Government has targeted an additional £11 million over the past seven years towards breastfeeding support. This extra funding has now been transferred to Health Boards so they can adapt their plans to suit local needs and it is particularly pleasing to see breastfeeding rates in the most deprived areas increasing.

“We have also seen good progress in Health Boards implementing the UNICEF UK Baby Friendly standards as a strong foundation for this work.

“Rates have increased in all Health Board areas since 2012/13 and we will keep building on this success as part of our continuing efforts to improve the health of the nation.”

Infant feeding statistics – Financial year 2024 to 2025 – Infant feeding statistics – Publications – Public Health Scotland

The Unicef UK Baby Friendly Initiative

Half of people with chest pain given all-clear for angina may be misdiagnosed using standard scan

A coronary angiogram does not detect microvascular angina, which is particularly common in women, so researchers say more tests are needed ~

 Half of people investigated for suspected angina and given the all-clear may be missing out on the correct diagnosis, based on a study funded by the British Heart Foundation, published in the journal Nature Medicine, and presented at the American Heart Association Scientific Sessions conference in New Orleans. 

The study involved 250 British people referred for a coronary angiogram after experiencing chest pain. Based on their scan results, these people did not have angina – the medical term for pain or tightness within the chest caused by reduced blood flow to the heart.  

However, when researchers gave these people an extra MRI scan, they found 51 per cent of people given the all-clear for angina actually had a form of it called microvascular angina. This is triggered by tiny blood vessels which can’t be seen using a standard coronary angiogram – where a thin tube is inserted into the wrist and up to the coronary arteries and an X-ray taken. The angiogram can only detect angina caused by blockages in the large coronary arteries. 

Researchers say blood flow scans should be used to follow up angiograms for every patient with unexplained chest pain, but that many regions of the UK do not currently offer this. 

Professor Colin Berry, senior author of the study from the University of Glasgow, said: “Further tests like the scan we used could help to reveal thousands more people with microvascular angina in the UK every year. Microvascular angina is currently particularly under-diagnosed in women. 

“We need these extra test results because people whose angiogram results suggest their chest pain is not heart-related can be sent home without medication, on the assumption that their symptoms are due to things like indigestion, anxiety or arthritis. 

“It is not uncommon for these people to then have to return to their GP multiple times, with continuing symptoms like chest pain and breathlessness.” 

Angina is a symptom of chest pain which can be caused by blockages or narrowing in the large coronary arteries which supply most blood to the heart. Microvascular angina used to be known as ‘cardiac syndrome X’ because it greatly confused doctors seeing patients with angina-like chest pains who didn’t have the expected narrowings or blockages in their coronary arteries.  

Now the name, coined in the 1970s, is no longer used because experts understand that the pain is caused by tiny arteries within the heart muscle – less than half a millimetre across – which play a crucial role in regulating blood supply to the heart. Women are more likely to have the condition than men, particularly around and after the time of menopause. 

Among the 250 people studied, all but six were judged to have chest pain that wasn’t heart-related based on their angiogram results. But the MRI scan found 123 of these people had microvascular angina – a diagnosis which is very clearly heart-related. 

The scan detects microvascular angina, which reduces blood flow to the heart, by showing inadequate blood supply after people are given a drug called adenosine, which mimics the demands of physical activity on the body. 

In the study, half of the 250 people were offered altered treatment based on their MRI scan result, if needed. Such treatment could include calcium channel blockers, which relieve angina and lower blood pressure, and aspirin and statins, which reduce their risk of heart attacks and strokes. 

This group were examined to see how receiving a new diagnosis, following further tests after a coronary angiogram, might change people’s lives. 

A better quality of life 

Researchers found quality of life was better for people whose treatment was changed based on their scan, compared to those whose treatment was not changed following their scan. This group also saw a bigger reduction in the frequency of their chest pain – from weekly to monthly on average. They had a larger reduction in their difficulty doing everyday activities, based on a questionnaire. 

A second questionnaire looked at people’s mobility, pain and discomfort, anxiety and depression and difficulties washing, dressing and performing normal daily activities. This also showed a greater improvement for people whose treatment changed based on their MRI scan. 

There is some evidence that having microvascular angina may increase the risk of having a heart attack or stroke, although this wasn’t seen in the 12-month period people were followed up in the study. 

People whose treatment was changed based on their MRI scan were found to have lower blood pressure, which may have been brought down by medications they were prescribed. They also had a lower weight, which researchers believe may have been a result of reduced chest pain making it easier to be active. 

Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation and consultant cardiologist, said: “Coronary microvascular dysfunction, which is seen more commonly in women, is real. It can have a serious impact on people’s everyday lives, as they struggle with chest pain and breathlessness, and is often misunderstood.  

“Unfortunately, many people go undiagnosed, are misdiagnosed, or are only diagnosed after years of delay, because the diagnosis of inadequate blood supply in tiny coronary blood vessels slips through the net.  

“This important study shows that it doesn’t have to be this way – having heart MRI tests improved chest pain diagnosis, which in turn led to changes in treatment and better health.” 

There were 127 people diagnosed with microvascular angina, including 123 whose angiogram had wrongly suggested their pain was not heart-related. The angiogram diagnosis that their chest pain was not heart-related appeared correct for 155 people. 

The MRI scans used in the study revealed two people judged not to have heart-related chest pain by an angiogram, who in fact had hypertrophic cardiomyopathy – a genetic condition which can cause a life-threatening abnormal heart rhythm. Another two people had myocarditis – inflammation of the heart muscle which most people recover from following treatment. 

There are around 250,000 coronary angiograms performed across the UK every year. The MRI scans in this study were done at the Golden Jubilee University National Hospital in Clydebank, within the west of Scotland. 

These scans judged blood flow in the blood vessels of the heart, and included an algorithm assessing the difference in flow between the inner and outer area of the heart, which is not routinely available on the NHS. However researchers say conventional MRI scans would have a largely similar performance. 

On how the study results should change NHS practice, Professor Berry added: “An angiogram alone is not enough for most people with suspected angina, but in most regions of the UK this is all that is performed. 

“People should be offered an additional test to look at blood flow. That does not need to be an MRI scan like ours, as there are several alternative tests which might be helpful. These tests are needed because debilitating chest pain significantly reduces people’s physical and mental wellbeing, and their ability to go about their everyday lives.” 

The study was also supported by the Chief Scientist Office in Scotland. 

Edinburgh Blue Balls launch first Annual – A bold celebration of men, mental health and community

Edinburgh Blue Balls, known for its cold-water dips and open conversations, launches its first Edinburgh Blue Balls Annual.

The coffee table–style publication is a bold and raw collection of portraits and personal stories told by men, for all to read.

The Annual is free of charge and distributed across independent cafés, bookshops and workplaces. A launch event will take place on 14 November at The Pitt, Granton, where everyone is welcome to see the portraits and meet the men behind the stories featured in the Annual.

Founded in 2021 by photographer Marc Millar, what began as a handful of strangers meeting for cold-water dips at Portobello Beach, has grown into a supportive community. Around 40 men now gather every Sunday and mid-week for dips, to connect, and talk openly about mental health.

Edinburgh Blue Balls exists to keep the conversation around men’s wellbeing alive. No membership, no expectations, just men showing up, sharing, and finding strength in connection.

The launch of the Annual marks the start of a growing body of creative work highlighting the lived experiences of men, from resilience and recovery to laughter and loss.

Featuring stories from men across Scotland and portraits by photographers Marc Millar and Graham Williams, the publication captures the unfiltered reality of men’s mental health.

The Annual also includes contributions from comedian Greg Hemphill and footballer Zander Murray, exploring masculinity, vulnerability, and visibility in sport and society.

Marc Millar, founder of Edinburgh Blue Ballssaid: “We spend too much time scrolling past things that deserve to stop us in our tracks.

“I wanted people to sit with these stories, to hold them, feel them, and connect. It’s not about likes or followers; it’s about being human, together.

“Everyday pressures continue to impact men’s mental health and wellbeing, something I’ve seen first-hand, and the stigma and shame that still exists.

“The stories in the Annual are honest, sometimes heavy, but full of hope. They show that even in the darkest moments, when men connect, talk, and support each other, things start to change.”

The Annual was supported by The National Lottery Community Fund and will be launched on the 14 November at The Pitt Market, Granton.

For more information please contact info@edinburghblueballs.co.uk

First Minister highlights importance of flu vaccination

The programme protects those most at risk from severe illness

The First Minister has urged all those eligible for a flu vaccination this year to take up the offer as he received his in Edinburgh.

Getting the flu vaccine is extremely important for those who are most vulnerable to the virus to protect them from severe illness and in some cases, death. Eligible groups include people 65 years and older, pregnant women and those with certain health conditions.

Unpaid carers and health and social care staff are also eligible as the vaccine helps prevent transmission of the virus so helps protect those they are caring for.   

The flu virus is always changing and the vaccination offers the best protection against the strains circulating each winter. Getting vaccinated ahead of the peak festive season is important to allow time for your body to build up protection against the virus.

First Minister John Swinney qualifies for a flu vaccine as an unpaid carer. Attending the NHS Lothian centre at Edinburgh’s Ocean Terminal he said: “I welcome the chance to receive my flu vaccine and I want to thank all those involved in this year’s roll-out.

“Since the start of this year’s programme, staff have delivered more than 980,000 flu vaccines to those most at risk and, with flu cases rising, I would encourage all those who are eligible to take up an appointment ahead of the worst of winter.

“We saw very high levels of the flu virus last year across Scotland, with over 6,500 adults being hospitalised, which contributed to real pressure on the NHS. So please take the opportunity to protect yourself and those around you and reduce your risk of ending up in hospital.”

Appointments for a flu vaccine will be sent to most eligible groups. Unpaid carers and household contacts of those who are immunosuppressed can book online or call the vaccination helpline to arrange an appointment at a suitable time and location anywhere in Scotland.

More information on the flu vaccine is available at NHS Inform:

www.nhsinform.scot/flu

Some people may also be eligible for other vaccines this year, including RSV and COVID-19. Information on these vaccines is available at: 

Winter vaccines | NHS inform and RSV vaccine for adults | NHS inform 

School children and pre-school children are also eligible for a free flu vaccine: 

Child flu vaccine | NHS inform

Expectant mothers invited to access charity’s new Smoking and Vaping During Pregnancy resources

ASH Scotland is encouraging expectant mothers in Edinburgh to access new free ‘Smoking and vaping during pregnancy’ resources developed by the health charity to increase awareness about the impact smoking and vaping has during pregnancy.

In Scotland, one in 12 women reported smoking at their first midwife appointment.

A new animated video and e-learning module produced by the charity aims to help expectant mothers to understand the links between cigarettes, e-cigarettes and pregnancy, know more about how tobacco and vaping affect the health and development of babies, and increase confidence to quit smoking.

Health damage associated with smoking is felt more intensely by pregnant women who are at higher risk of experiencing illness and complications. Evidence also shows that second-hand smoke poses serious health risks to infants, with exposure leading to an increased chance of developing asthma, respiratory infection and sudden infant death.

The World Health Organization states that foetal exposure to e-cigarette vapour can negatively impact development. Partners or family members who smoke or vape in the home should be encouraged to do so outside during pregnancy and after the birth.

Sheila Duffy, Chief Executive of ASH Scotland, said: “Addiction is not a lifestyle choice – it is a public health concern and a social justice issue and expectant mothers in Edinburgh can give their baby the best start in life by quitting smoking.

“A mother quitting smoking prior to pregnancy reduces the potential of health risks affecting their baby to near non-smoker levels andASH Scotland wants to ensure that they are empowered to seek support to give up.

“We trust that our new ‘Smoking and vaping during pregnancy’ animated video and e-learning module will help inform expectant mothers across Edinburgh about the many benefits of giving up smoking.”

The new resources are available at ASH Scotland’s website here.

Whooping cough vaccine successful in reducing hospitalisations

Findings from a paper published in the medical journal, Eurosurveillance, show that fully vaccinated children aged 8 weeks to 17 years were 69% less likely to be hospitalised with whooping cough (pertussis).

The study, which looked at the impact of vaccination on whooping cough-related hospital admissions in children between January 2013 – July 2024, demonstrates the significant protective effect of this childhood vaccination. Being fully vaccinated for their age also reduced the risk of whooping cough-related hospital stays in babies aged 8 weeks to 1 year by 88%.

Whooping cough is a highly contagious bacterial infection of the lungs and airways, and this latest evidence confirms that unimmunised infants are more likely to develop complications which can require hospital treatment.

The study also found lower vaccine uptake in deprived areas, highlighting the need to focus efforts on addressing the persistent health inequalities that leave some communities more vulnerable with others. 

Dr Sam Ghebrehewet, Head of Vaccination and Immunisation Division, PHS said: “This important study clearly highlights the remarkable power of vaccinations to protect children from serious and potentially life-threatening diseases like whooping cough.

“By ensuring children are fully vaccinated, we can dramatically reduce hospitalisations and complications, safeguarding their health and giving families peace of mind.

“Getting immunised during pregnancy is the best way to protect your baby in the first few vulnerable weeks of their life. All pregnant women are eligible for the whooping cough vaccine from week 16 of their pregnancy. The ideal time to get it is between weeks 16 and 32. The whooping cough vaccine is recommended every time you’re pregnant, even if you’ve had the vaccine before.

“It is also extremely important that parents or carers ensure their babies get their whooping cough vaccine which is given at 8, 12 and 16 weeks as part of the 6-in-1 vaccine.”

Read the study in full

Pregnant women are encouraged to speak to their midwife about getting the whooping cough vaccine; and you can find more about pregnancy and baby immunisations: www.nhsinform.scot/pregnancyandbabyvaccines

Parents are encouraged to contact their local NHS Immunisation team to arrange for their children to get vaccinated if they have missed any doses. Contact details can be found at www.nhsinform.scot/gettingvaccinations or by calling 0800 22 44 88.

If you have any concerns about symptoms of whooping cough, speak to your GP practice or phone 111.

New study shows long-term effectiveness of HPV vaccine

An encouraging new study by Public Health Scotland, in collaboration with the Universities of Edinburgh and Strathclyde, confirms the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.

Data from the study, published in International Journal of Cancer today, show that the HPV vaccine provides protection when administered to girls aged 18 years or less, with the greatest benefits seen in girls vaccinated at age 12-13.

Previous studies have shown that the HPV vaccine is highly effective in preventing the development of cervical pre-cancer and cancer. This study using population health data, shows that the vaccine continues to be effective more than 12 years after it was given, in women who came forward for cervical screening.  

The research also shows women from Scotland’s most deprived areas benefited the most from vaccination, helping to reduce health inequalities.

HPV is a common virus, usually spread through sexual contact, and responsible for almost all cases of cervical cancer – the fourth-most common cause of cancer in women worldwide. Scotland’s routine cervical cancer screening programme and the HPV immunisation programme, introduced in 2008, work together to both reduce the prevalence of HPV and the development of cervical pre-cancer and cancer among women. 

The HPV vaccine is offered as a routine immunisation through schools to all S1 pupils in Scotland. It also helps to protect both boys and girls from genital warts and other HPV-related cancers that can develop later in life, such as some head and neck cancers, and other anogenital cancers.  

Dr Kirsty Roy, Consultant in Public Health, Public Health Scotland said: “This study showcases both the effectiveness and impact of the HPV vaccine in preventing cervical disease, especially as the strong community protection demonstrated by the data may also be contributing to reductions in cervical disease among women in more deprived areas where vaccine uptake is lower.

“Vaccination against HPV is effective in preventing cervical cancer and, along with regular screening for early detection and treatment, it is possible to make cervical cancer a rare disease.

“I would encourage all S1 pupils in Scotland to take up the offer of the free HPV vaccine when it’s offered to protect themselves against future risks. PHS is working closely with Scottish Government and local health boards to ensure the continued uptake of the key cervical cancer prevention measures – the HPV vaccine and routine cervical screening.” 

Dr Tim Palmer, University of Edinburgh, Scottish Clinical Lead for Cervical Screening (rtd), said: “This study shows conclusively that the HPV vaccine prevents the changes that can develop into cancer.

“It also emphasises the need for continued high uptake of the vaccine in schools as vaccination at older ages is much less effective. Screening is still important to prevent disease caused by HPV types not covered by the vaccine.”

Read the full study: Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening 

More information about the HPV vaccine, and when and where to get it is available on NHS Inform  

More information on Cervical Screening can be found on Cervical screening (smear test) in Scotland | NHS inform 

RCEM asks Scottish government: ‘Where is the tangible plan for winter?’

Emergency Departments record worst-ever September performance

Accident and Emergency

As Scotland’s Emergency Departments experienced the worst September on record for performance, the Royal College of Emergency Medicine has asked the government: ‘where is the tangible plan for winter?’ 

The figures, released yesterday (4 November 2025) by Public Health Scotland, come as Health Secretary, Neil Gray, is reported to have said waiting times in A&E are ‘below the levels we all wish to see’.  

The PHS data, for the month of September, reveals 6,427 patients waited 12 hours or longer in an Emergency Department before being admitted, discharged, or transferred.  

That’s around one in every 19 people and the highest number who experienced this wait for the month of September since records began in 2007.  

The data, for major EDs in Scotland, also showed that in September 2025: 

  • 12-hour waits were almost 34 times worse than in September 2018 – that’s despite the number of people attending EDs only increasing by 4.5% in the same period 
  • One in eight people (15,348) waited eight hours or more to be discharged or transferred – the worst September on record 
  • 63.7% of patients were seen within four hours – again, the worst September on record and is far below the government’s target of 95% 
  • There was an average of 1,955 beds occupied by people healthy enough to be discharged – a decrease of only nine compared to the previous month 

The new data comes shortly after RCEM published its political manifesto for Scotland, urging all political parties to end overcrowding in EDs, and provide enough Emergency Medicine staff to deliver safe and sustainable care, along with adequate resources to ensure equitable care throughout the emergency care system.  

Meanwhile, recently published analysis from the College revealed there were more than 800 deaths associated with long A&E waits before admission last year. 

Dr Fiona Hunter, RCEM Vice President for Scotland, said: “These figures prove what I and many other EM clinicians already know – that we are in crisis and the depths of winter, when the inevitable seasonal pressure hits, is yet to arrive.  

“Our members and their Emergency Medicine colleagues tell me about the relentless pressure their hospitals are under and the impact this has on patient care – people are being treated in ambulances, in corridors, and other inappropriate spaces.  

“Our EDs don’t have elastic walls. These are visual signs our hospitals are full to bursting– we can’t move patients from our departments into wards because of a lack of available inpatient beds.  

“On top of dealing with system pressures, our clinicians are facing violence and aggression from those we are trying our best to care for – that can be caused by frustration over long waits. It’s beyond unacceptable.  

“We know that Scottish Health Secretary understands the scale of the issue, and just today acknowledged that ‘ED performance is below where it should be’.  

“But we are yet to see any tangible plan from the government about how it intends to tackle the season ahead – which will be nothing short of challenging.” 

Additional £25.5 million for planned care

Delivering extra appointments and procedures for patients

Health boards will receive an additional £25.5 million this year to allow them to deliver more planned care appointments and procedures to reduce long waits for patients, First Minister John Swinney has announced.

The additional funding will support the delivery of more outpatient appointments and inpatient/day case procedures across a variety of specialities including orthopaedics, dermatology, general surgery and gynaecology. Cardiology and paediatrics will also get extra funding.

This new support takes total additional investment to £135.5 million in 2025-26 to help the National Health Service maintain progress on reducing waiting lists.

Recent figures show the total list size and longest waits are coming down. There has also been an increase of more than 31,000 appointments and procedures from April to September this year compared to same period in 2024.

Speaking during a visit to Queen Elizabeth University Hospital in Glasgow, the First Minister said: “The latest figures show our plan to support Scotland’s NHS is working, delivering real benefits for patients.

“We have already provided £110 million of additional targeted funding this year to tackle the longest waits. Now we are providing a further boost to deliver more appointments and procedures, taking the total additional funding to £135.5 million for 2025-26.

“I am determined to build on the progress being achieved by hardworking staff in our health service, like those I met today at Queen Elizabeth University Hospital. We want to help them provide the care and treatment patients need and expect – and we are already seeing results.

“Not only are the total list size and longest waits coming down, but we are treating more people than last year. There is still work to be done, but these are very welcome improvements.

“Under my leadership, the people of Scotland can expect a strong National Health Service delivering patient care of the highest possible quality.”

The additional £25.5 million will be shared between the following health boards:

  • Ayrshire and Arran
  • Fife
  • Grampian
  • Greater Glasgow and Clyde
  • Highland
  • Lanarkshire
  • Lothian
  • Shetland
  • Tayside

In NHS Greater Glasgow and Clyde, as at 30 September 2025, new outpatient ongoing waits over 52 weeks had decreased by 17.6% and inpatient/day case ongoing waits over 52 weeks had decreased by 5.7% compared to the previous month.

Reduction in NHS waiting lists – gov.scot